Related content

Mammalian target of rapamycin as a target in hematological malignancies

By Kelly Kevin  

Targeted Oncology, Vol. 6, Iss. 1, 2011-03 ,pp. : 53-61

Springer Publishing Company

Access to resources Recommend Favorite

microRNA199a is able to reverse cisplatin resistance in human ovarian cancer cells through the inhibition of mammalian target of rapamycin

By Wang Zhongxian   Ting Zhou   Li Ya   Chen Gang   Lu Yunping   Hao Xing  

Oncology Letters, Vol. 6, Iss. 3, 2013-09 ,pp. : 789-794

Spandidos Publications

Access to resources Recommend Favorite

Clinical significance of aberrant mammalian target of rapamycin expression in stage IIIB colon cancer

By                

Oncology Letters, Vol. 8, Iss. 3, 2014-01 ,pp. : 1080-1086

Spandidos Publications

Access to resources Recommend Favorite

Inhibition of mammalian target of rapamycin by rapamycin increases the radiosensitivity of esophageal carcinoma Eca109 cells

By                

Oncology Letters, Vol. 8, Iss. 2, 2014-01 ,pp. : 575-581

Spandidos Publications

Access to resources Recommend Favorite

The emerging role of mammalian target of rapamycin inhibitors in the treatment of sarcomas

By Vemulapalli Sushma  

Targeted Oncology, Vol. 6, Iss. 1, 2011-03 ,pp. : 29-39

Springer Publishing Company

Access to resources Recommend Favorite